CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-25 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −250 | $439.94 | $110K | 35,425 |
| 2022-04-11 | Patterson Chad EVP, Global Marketing | Sale | −776 | $498.75 | $387K | 14,452 |
| 2022-03-29 | Regan Barry J. EVP Global Operations | Sale | −1,106 | $500.00 | $553K | 16,345 |
| 2022-03-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −250 | $459.98 | $115K | 35,675 |
| 2022-03-17 | Dolan Matthew Vincent SVP Corporate Development | Sale | −484 | $450.00 | $218K | 6,634 |
| 2022-03-16 | Dolan Matthew Vincent SVP Corporate Development | Sale | −686 | $425.00 | $292K | 7,118 |
| 2022-03-15 | Dolan Matthew Vincent SVP Corporate Development | Sale | −1,016 | $412.41 | $419K | 7,804 |
| 2022-03-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −445 | $405.84 | $181K | 100,438 |
| 2022-03-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −405 | $407.00 | $165K | 100,033 |
| 2022-03-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −150 | $407.60 | $61K | 99,883 |
| 2022-03-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −400 | $408.89 | $164K | 99,483 |
| 2022-03-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −445 | $410.00 | $182K | 99,038 |
| 2022-03-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −405 | $411.25 | $167K | 98,633 |
| 2022-03-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −450 | $412.27 | $186K | 98,183 |
| 2022-03-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −50 | $413.51 | $21K | 98,133 |
| 2022-03-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −100 | $414.99 | $41K | 98,033 |
| 2022-03-15 | SAYER KEVIN R Chairman, CEO & President | Sale | −150 | $416.42 | $62K | 97,883 |
| 2022-03-10 | Patterson Chad EVP, Global Marketing | Sale | −776 | $401.27 | $311K | 15,228 |
| 2022-03-10 | Selvaraj Shelly Ramasamy SVP Chief Information Officer | Sale | −2,366 | $401.27 | $949K | 11,454 |
| 2022-03-09 | Sylvain Jereme M EVP, Chief Financial Officer | Returned to the company | −491 | $406.06 | $199K | 19,468 |
Page 23 of 40 · 785 trades